Skip to main content
. Author manuscript; available in PMC: 2013 Nov 1.
Published in final edited form as: Ann Thorac Surg. 2012 Jul 12;94(5):1509–1517. doi: 10.1016/j.athoracsur.2012.05.052

Fig 4.

Fig 4

Representative immunoblots for (A) angiostatin, (B) endostatin, and (C) tumstatin after MMP-9 inhibition. As indicated by the bar graphs, there was a significant down-regulation of angiostatin (*p = 0.04), endostatin (*p = 0.002), and tumstatin (*p = 0.05) in hypertrophied hearts receiving an MMP-9 inhibitor. Equal protein loading was confirmed by staining of gels with Coomassie brilliant blue.